| Gene symbol | HA | Synonyms | None | Type of gene | protein-coding |
| Chromosome | - | Map location | NC_002017.1 (33..1733) | dbXrefs | |
| Description | haemagglutinin | ||||
| GTO ID | GTC1433 |
| Trial ID | NCT01688297 |
| Disease | Influenza |
| Altered gene | HA |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | dsRNA |
| Treatment | VXA-A1.1|Ad-HA-dsRNA |
| Phase | Phase1 |
| Recruitment status | Completed |
| Title | Randomized Phase 1 Double-Blinded Placebo Controlled Trial to Determine the Safety and Immunogenicity of an Adenoviral-Vector Based Seasonal Influenza A Vaccine and dsRNA Adjuvant Administered Orally to Healthy Volunteers |
| Year | 2012 |
| Country | United States |
| Company sponsor | Vaxart |
| Other ID(s) | VXA02-001 & VXA02-003 |
| Vector information | |||||||||||
|
|||||||||||
| Cohort1: VXA-A1.1_dose level 1 | |||||||
|
|||||||
| Cohort2: Placebo | |||||||
|
|||||||
| Cohort3: VXA-A1.1_dose level 2 | |||||||
|
|||||||
| Cohort4: VXA-A1.1_dose level 3 | |||||||
|
|||||||